Clinical Trial Update: Intranasal Glutathione in Parkinson's Disease [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating intranasal glutathione in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Glutathione (glutathione)

Snippet

Sponsor: Bastyr University | Conditions: Parkinson's Disease (PD) | Phase 1 | Status: COMPLETED